Efficacy of Hyaluronic Acid in Radiation Proctitis: A Case Series
Keywords:
radiation proctitis, hyaluronic acid, enemaAbstract
Gastrointestinal toxicities of radiation might develop after exposure, thus leading to conditions such as abdominal pain, rectal bleeding, diarrhea, anemia, and weight loss. The development of drugs to reduce mucosal damage progression has been a focus on managing radiation proctitis. Radiation proctitis resulting from exposure to pelvic radiotherapies is effectively managed with topical administration on the anal mucosa. The clinical use of hyaluronic acid offers an innovative approach to managing radiation injury. Hyaluronic acid has multiple beneficial properties, such as regulating immune process to reduce inflammation and oxidative stress, supporting natural protective mechanism, promoting mucosa healing, and improving tissue hydration. Therefore, this case series introduces the idea that application of hyaluronic acid could potentially improve patients’ clinical conditions.References
Williams HRT, Vlavianos P, Blake P, Dearnaley DP, Tait U, Andreyev HJN. The significance of rectal bleeding after pelvic radiotherapy. Aliment Pharmacol Ther. 2005;21(9):1085–90.
Paquette IM, Vogel JD, Abbas MA, Feingold DL, Steele SR. The American society of colon and rectal surgeons clinical practice guidelines for the treatment of chronic radiation proctitis. Dis Colon Rectum. 2018;61(10):1135–40.
Cosentino D, Piro F. Hyaluronic acid for treatment of the radiation therapy side effects: a systematic review. Eur Rev Med Pharmacol Sci. 2018;22(21):7562–72.
Jaffray DA, Gospodarowicz MK. Radiation therapy for cancer. Disease Control Priorities, Third Edition (Volume 3): Cancer. 2015;3:239–47.
Araujo IK, Muñoz-Guglielmetti D, Mollà M. Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options. Best Practice & Research Clinical Gastroenterology. 2020;48-49:101707.
Ahmed M, Ahmed R. Radiation in gastroenterology. Gastroenterology Research. 2022;15(6):285–96.
Do NL, Nagle D, Poylin VY. Radiation proctitis: current strategies in management. Gastroenterology Research and Practice. 2011;2011:1–9.
Dahiya DS, Kichloo A, Tuma F, Albosta M, Wani F. Radiation proctitis and management strategies. Clinical Endoscopy. 2021.
Jhingran A. Complications of radiation oncology. Principles of Gynecologic Oncology Surgery. 2018;318–29.
Porouhan P, Farshchian N, Dayani M. Management of radiation-induced proctitis. Journal of Family Medicine and Primary Care. 2019;8(7):2173–8.
Lee J, Hee Dong Han, Byung Soh Min, et al. The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer. Japanese Jurnal of Oncology. 2018;48(11):988–94.
Fuccio L, Guido A, Andreyev HJN. Management of intestinal complications in patients with pelvic radiation disease. Clinical Gastroenterology and Hepatology. 2012;10(12):1326-1334.e4.
Motte CA, Kessler SP. The role of hyaluronan in innate defense responses of the intestine. International Journal of Cell Biology. 2015;2015:1–5.
Riehl TE, Foster L, Stenson WF. Hyaluronic acid is radioprotective in the intestine through a tlr4 and cox-2-mediated mechanism. American Journal of Physiology. 2012;302(3):G309–16.
Ferini G, Tripoli A, Umina V, et al. Radiation proctitis: The potential role of hyaluronic acid in the prevention and restoration of any damage to the rectal mucosa among prostate cancer patients submitted to curative external beam radiotherapy. Gastroenterology Insights. 2021;12(4):446–55.
Delia P, Sansotta G, Pontoriero A, et al. Clinical evaluation of low-molecular-weight hyaluronic acid-based treatment on onset of acute side effects in women receiving adjuvant radiotherapy after cervical surgery: a randomized clinical trial. Oncol Res Treat. 2019;42(4):212–8.
Laliscia C, Delishaj D, Fabrini MG, et al. Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit? J Contemp Brachytherapy. 2016;8(6):512.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.